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Abstract 
This review will highlight evidence from crew members flown on space missions >90 days to 
suggest that the adaptations of the skeletal system to mechanical unloading may predispose crew 
members to an accelerated onset of osteoporosis after return to Earth.  By definition, osteoporosis is a 
skeletal disorder − characterized by low bone mineral density and structural deterioration − that reduces 
the ability of bones to resist fracture under the loading of normal daily activities. “Involutional” or age-
related osteoporosis is readily recognized as a syndrome afflicting the elderly population because of the 
insipid and asymptomatic nature of bone loss that does not typically manifest as fractures until after age 
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~60. It is not the thesis of this review to suggest that spaceflight-induced bone loss is similar to bone loss 
induced by metabolic bone disease; rather this review draws parallels between the rapid and earlier loss 
in females that occurs with menopause and the rapid bone loss in middle-aged crew members that occurs 
with spaceflight unloading and how the cumulative effects of spaceflight and ageing could be 
detrimental, particularly if skeletal effects are totally or partially irreversible. 
In brief, this report will provide detailed evidence that long-duration crew members, exposed to 
the weightlessness of space for the typical long-duration (4-6 months) mission on Mir or the 
International Space Station -- 
1. Display bone resorption that is aggressive, that targets normally weight-bearing skeletal sites, 
that is uncoupled to bone formation and that results in areal BMD deficits that can range 
between 6-20% of preflight BMD; 
2. Display compartment-specific declines in volumetric BMD in the proximal femur (a skeletal 
site of clinical interest) that significantly reduces its compressive and bending strength and 
which may account for the loss in hip bone strength (i.e., force to failure); 
3. Recover BMD over a post-flight time period that exceeds spaceflight exposure but for which 
the restoration of whole bone strength remains an open issue and may involve structural 
alteration; and 
4. Display risk factors for bone loss -- such as the negative calcium balance and down-regulated 
calcium-regulating hormones in response to bone atrophy -- that can be compounded by the 
constraints of conducting mission operations (inability to provide essential nutrients and 
vitamins).   
The full characterization of the skeletal response to mechanical unloading in space is not 
complete. In particular, countermeasures used to date have been inadequate and it is not yet known 
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whether more appropriate countermeasures can prevent the changes in bone that have been found in 
previous flights, Knowledge gaps related to the effects of prolonged (> 6months) space exposure and to 
partial gravity environments are substantial, and longitudinal measurements on crew members after 
spaceflight are required to assess the full impact on skeletal recovery. 
Introduction 
Early in the space program, it was recognized that immobilization in those first space crafts for 
manned missions, coupled with the gravitational unloading, could have detrimental effects on calcium 
metabolism. The impetus behind the next 40+ years of bone research in space may have come in the 
1940’s when the premier endocrinologist, Fuller Albright, called attention to the disturbed calcium 
metabolism evident in a young patient experiencing prolonged bed rest [1].  This was subsequently 
proven by Whedon and colleagues in studies demonstrating that musculoskeletal atrophy was due to the 
mechanical unloading of prolonged bed rest and not disease per se [2].  Consequently, seminal 
investigations and evaluations of the skeletal system were initiated with the Gemini flights, as best as 
could be achieved given the constraints of operating a spaceflight mission and the available technology 
in the early 1960’s.  As technology has advanced, so has the characterization of skeletal adaptation to 
weightlessness.  As outlined in Figure 1 the database for the skeletal effects of spaceflight was expanded 
along with the technologies and analyses available during a spacecraft era. 
To this day, the characterization of skeletal adaptation to space (termed “space normal” by the 
NASA Human Research Program at Johnson Space Center) is paramount as NASA prepares to embark 
on exploration class missions with a return to the moon and human exploration of other planetary 
surfaces.  Understanding the physiological effects of spaceflight is critical as NASA identifies the health 
risks associated with these longer-duration flights and develops appropriate countermeasures to 
eliminate or mitigate these effects.   While the current understanding of “space normal” for bone has 
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been limited by the number of crewmembers and flight opportunities, the current database on the 
skeletal adaptation to space provides sufficient evidence to document that prolonged exposure to the 
space environment without appropriate countermeasures, compromises the skeleton and may increase 
the risk for atraumatic fractures at an earlier age.  
In order to understand how the adaptive response to space predisposes crew members to early 
onset osteoporosis it is important to appreciate how space exposure impacts the multiple facets of 
skeletal remodeling and how those changes in crew members (predominantly driven by biomechanics) 
relate to terrestrial changes in the ageing human (predominantly driven by metabolic pathologies).   
Background  
Osteoporosis is a skeletal disease characterized by several features of a deteriorated skeleton that 
collectively compromise whole bone strength and increase the propensity for fracture in afflicted 
individuals. This syndrome can be a consequence of the ageing process [3, 4] which begins during late 
puberty following the closure of epiphyseal growth plates.  However, the sex-specific effects of growth 
also influence age-related bone loss since estrogen suppression of radial and longitudinal bone growth in 
females, with the onset of puberty, results in smaller bones and less peak bone mass compared to their 
male counterparts.  Later, with the onset of menopause, estrogen-deficient females experience an earlier, 
more rapid, phase of involutional bone loss which increases the incidence and prevalence of fractures in 
ageing women [3-5].   Likewise, it is widely acknowledged that osteoporosis can be induced by 
secondary factors, such as chronic use of glucocorticoid medication, alcoholism or decreased physical 
activity where the suppressive effects on bone formation unbalance the remodeling process to favor net 
bone loss.   Thus, osteoporosis has multiple pathophysiologies that can have additive effects.   
After more than 40 years of human spaceflight, the mechanical unloading of space is a well-
recognized risk factor for bone loss [6].  Whether it is a factor for secondary osteoporosis in crew 
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members is dependent upon the length of time the skeleton is unloaded in space and whether it can be 
restored to its previous pre-launch state upon return to normal mechanical loading of Earth.  If the 
skeletal decrements during space travel are irreversible, even if osteoporosis is not diagnosed at landing, 
the result may be an earlier diagnosis in the crew member’s life compared to the expected temporal 
onset with age-related bone loss.  Understanding the skeletal response to the mechanical unloading of 
spaceflight starts with understanding how the adult skeleton undergoes bone turnover through the highly 
mediated process of bone remodeling in a standard gravitational field. 
On Earth, the adult human skeleton renews and repairs itself with approximately one tenth of the 
skeleton renewed on an annual basis. In response to putative osteocytic cell signaling, skeletal 
remodeling is initiated in discrete packets of skeletal tissue referred to as “bone remodeling units” where 
the removal and replacement of bone tissue is the result of a well-orchestrated action of bone resorbing 
(osteoclasts) and bone forming cells (osteoblasts). This cellular regulation ensures: i) the temporal 
formation of bone after the resorption of bone (i.e., “bone coupling”); and ii) the spatial formation of a 
bone volume to replace the resorbed volume in the resorption pit or lacunae (“bone balance”). Any 
perturbation to this cellular process, e.g., induced by endocrine or nutritional deficiencies or by changes 
in mechanical stresses, can disrupt this balance in the bone remodeling unit resulting in a deficit of bone, 
a gain of bone or a change in material properties of bone. With 1-2 million bone remodeling units in the 
adult skeleton [7], a negative balance of bone in each unit can reduce skeletal mass over time and 
compromise the skeleton’s integrity under normal mechanical loading.   
When remodeling is accelerated, as with menopausal bone loss, the “birth rate” of bone 
remodeling units is high.  This acceleration can be quantified by histomorphometry with the index of 
Activation Frequency which has been shown to increase in the ageing female (Figure 2) [8].  
Histomorphometric analyses have further revealed how increased numbers of bone remodeling units can 
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perforate horizontal trabecular struts of cancellous bone microarchitecture and induce greater porosity in 
cortical bone.  The loss of trabecular elements and of connectivity between trabeculae reduces the 
mechanical strength of the trabecular scaffold.  The accelerated loss of bone with menopause targets the 
cancellous bone compartment (i.e., trabecular or spongy bone) where resorption preferentially occurs 
along the bone surfaces adjacent to bone marrow. This mechanism of bone loss leads to: i) thinning of 
the cortical bone shell and the trabecular plates; ii) perforation of trabecular struts and iii) loss of 
trabecular elements and connectivity [5, 9, 10].  With menopause, there is a 20-30% reduction in 
cancellous bone compared to the 5-10% losses cortical bone associated with the first decade after 
menopause and accounting for a higher incidence of fractures in women (compared to men of same age 
range) at those skeletal sites predominantly composed of cancellous bone (wrist fractures and vertebral 
crush fractures) [3].  Increased remodeling, moreover, can also be inferred by increased levels of 
biomarkers for bone formation and bone resorption [11, 12].  
More recently, the application of the more sensitive quantitative computed tomography [QCT] to 
a population study substantiated that there are earlier and persistent losses in cancellous bone in both 
men and women (~33% and 50% of total lifetime loss, respectively) [13, 14]. Likewise, substantial 
losses in cortical bone in women were initiated around mid-life with menopause onset while cortical 
bone loss in men did not accelerate until much later. Together with the observation that women have 
smaller bones from the outset, the deficiency of estrogen with menopause is a major contributing factor 
to osteoporosis (and its associated fragility fractures) in women compared to men at the same age. 
The knowledge base underlying the spaceflight-induced bone loss is limited in comparison to 
what is known about the pathophysiology of primary osteoporosis or for the cellular mechanisms of 
secondary osteoporosis in the terrestrial populations.  Spaceflight missions do not typically provide 
controllable experimental conditions for the systematic collection of data; experiments are restricted by 
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power, mass, and volume requirements; flight opportunities are few and far between; and subjects for 
testing or for longitudinal measures are too few to obtain definitive answers.  Even so, the limited data 
from spaceflight can be evaluated in the context of the extensive knowledge base for terrestrial 
osteoporosis. 
Hence this review of spaceflight analyses will span the perturbations in calcium homeostasis and 
in bone remodeling that were detected with short durations of spaceflight (<90 days as defined herein, 
but typically <2-3 weeks based on mission durations) to the measurable decrements in bone mineral 
densities and in bone structure in “long-duration” crew members after spaceflight exposures of typically 
~4-6 months.  Also described is the computer modeling -- based upon data from 3-dimensional bone 
images -- that has enabled estimations of hip bone strength immediately following long duration 
missions.  A summary of knowledge gaps will highlight work that remains to be done, with spaceflight 
and/or with ground-based analogs, to substantiate the risk for an earlier onset of osteoporosis in crew 
members after prolonged space missions. 
HUMAN SPACEFLIGHT DATA 
Evidence for perturbed bone remodeling 
There is evidence from bone turnover markers to suggest that the remodeling process is 
uncoupled in space leading to an unbalanced remodeling of bone and a deficit in bone mass. Indirect 
measures of turnover at the level of the entire skeleton indicate increased bone resorption, while bone 
formation appears to be unchanged or decreased. Early in the space program, biochemical assays of 
specimens collected in flight detected a greater excretion of collagen degradation products relative to 
circulating proteins/peptides that are synthesized and released by osteoblasts during bone formation.  
Increased bone resorption was evident with the elevated excretion of hydroxyproline relative to pre-
flight level detected in all 3 Skylab missions [15]; this finding was corroborated almost two decades 
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later when archived urine specimens were analyzed by state-of-the-art assays for cross-linked collagen 
fragments (e.g., N-telopeptide, NTX) [16].  Likewise, Smith et al. [17] documented how spaceflight 
increased NTX excretion, with minimal influence on circulating levels of the osteocalcin, as determined 
in flight specimens of Mir crews.  This pattern supported the earlier evidence of suppressed circulation 
of procollagen type I C-terminal peptide, bone-specific alkaline phosphatase, and osteocalcin (i.e., 
formation markers), concurrent with increased excretion of bone resorption markers in the Mir crew 
members [18].  Furthermore, measurement of C telepeptide (CTX) in both urine and serum in the two 
Mir cosmonauts indicated a greater concentration in serum as early as 8 days into the flight.  An increase 
in undercarboyxlated bone gla protein (i.e, osteocalcin) was evident suggesting an impairment of 
vitamin K metabolism, the origins of which remain to be further investigated [19].  Collectively, these 
systemic indices of bone turnover suggest that mechanical unloading uncouples bone remodeling and, 
due to the “aggressive” action of osteoclasts, the resorbed volume of bone exceeds the volume of bone 
formed by osteoblasts. 
Presence of additional risk factors for bone loss  
Bone loss in space reflects alterations in many processes. There are several risk factors present in 
crew members during and immediately after spaceflight, some of which may contribute to or may be a 
consequence of the bone loss induced by spaceflight. Mineral metabolic studies that were conducted 
during the 28, 56, and 84-day Skylab missions enabled Whedon and colleagues to characterize the 
negative calcium (and mineral) balance with spaceflight [20-22].  Despite the large variability in the 
results, collectively the data suggested that skeletal deconditioning increased with longer mission 
durations [23]. There was a rapid and sustained elevation in urine calcium, a gradual increase in fecal 
calcium, and a negative calcium balance averaging – 7.5g/month. These changes were accompanied by 
increased excretion of hydroxyproline and hydroxylysine (early biomarkers of bone resorption), gradual 
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decreases in intestinal calcium absorption, minor increases in plasma calcium and phosphorus, and a 
delayed (>4 weeks) reduction in serum parathyroid hormone (PTH).  The data suggested that the 
negative calcium balance was likely due to bone atrophy (increased excretion) and to calcium mal-
absorption (decreased intake).  
Measurements of calcium-regulating hormones in Mir crews showed trends for reduced 
parathyroid hormone [PTH] and 1, 25 dihydroxylated vitamin D concurrent with signs of increased bone 
resorption during spaceflight [17, 24]; the lack of statistical significance was likely a consequence of 
small subject numbers. These flight data further documented how increased atrophy of bone mildly 
increases serum calcium and phosphorus, leading to the reductions in calcium-regulating hormones, to 
the poor conservation of calcium, and contributing to the negative calcium balance observed with 
spaceflight [17, 25].   
Changes in bone mass, bone mineral density and bone structure 
Evaluations of bone density following prolonged space exposure were initially implemented with 
the 3-manned crew of the Skylab missions and thus first demonstrated the regional specificity of bone 
loss in space. Measurements by single photon absorptiometry failed to show any impact of spaceflight to 
measurements in the upper body (wrist), but detected significant losses in the lower extremity 
(calcaneus, in 3 of 9 astronauts) [26]. BMD changes in crews of different missions became more 
negative with increasing duration of Skylab flights (28, 56, and 84 days) [Figure 3] [15]. Similarly, 
Oganov [27] analyzed spine BMD with early application of computed tomography (CT). Evidence from 
four Russian cosmonauts, after 5-7 month space missions, similarly displayed large variability with 
losses in vertebral BMD in three cosmonauts (0.3% to 10.8%) and a gain of 2.3% in one cosmonaut 
[27]. 
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 It was with the advent of DXA technology that the measurements of areal BMD showed 
changes that suggested accelerated bone turnover at skeletal sites that were normally weight-bearing on 
Earth. LeBlanc et al [28] conducted DXA BMD measurements of crew members (n=16-18) before and 
after serving on the Mir spacecraft (~4 month duration) to report a BMD change over an entire mission.  
However, because of the wide range of mission durations (~4 to 14 months) during this data-collection 
period, BMD losses were normalized to total months-in-space to report an averaged monthly loss of 1-
1.5% loss (Table 1). Further assessment revealed large variability in BMD losses amongst crew 
members, both intraskeletally and interskeletally, and that the BMD losses were greater in the lower 
limbs and at weight-bearing sites of the central skeletal. These sites included the hip and spine, sites 
which have a high incidence of osteoporosis fractures in the elderly population on Earth.  Based upon 
these flight data, and the precision evaluation for the densitometry machines, DXA measurement of 
BMD is only applied to crew members serving on spaceflight missions >30 days. 
The averaged 1-1.5% monthly loss in BMD in crew members is truly accelerated compared to 
the 2-3% loss per year observed in postmenopausal females during what is characterized as the rapid 
bone loss phase the first decade after menopause onset [3]. Additionally, Figure 4 a,b provides a 
comparison of longitudinal changes in total hip BMD as a function of age for both men and women as 
reported by Warming [29]; overlaid on the bar graph are data derived from crew members who served 
on missions on the International Space Station [ISS] and the Russian Mir spacecraft.    
These population changes were measured over 2 years and compared to averaged BMD changes 
in long-duration crew members over the typical 6 month mission. For hip BMD, crew members in the 
age range 35-55 display a ~6 fold greater decrement after a 6-month spaceflight mission compared to the 
losses incurred over 24 months in men of comparable age. Comparisons of age-related losses in BMD 
were also conducted for the clinically relevant sites of forearm and spine where male crew members 
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displayed large BMD variability in the lumbar spine and forearm (Figure 4 c, d),   The losses quantified 
in the long duration female crew members may be comparable to losses measured in the 50-59 
population age group (Figure 4 e, f) but currently the number of subjects is small (n=3). 
Reductions in bone volumetric density, size and structure 
There is evidence that indicates a differential loss of mineral mass in bone compartments. A 
preferential BMD loss in cancellous vs. cortical bone compartments (on basis of percentage) has been 
detected in both Russian and US crew serving in long duration (>30 day to 6-month missions) as 
determined by peripheral QCT and QCT technology [30, 31].  In particular, QCT scans performed in the 
spine and the total hip (femoral neck and proximal femur) of crew members serving on six-month 
missions on ISS, quantified trabecular bone losses of 2.2-2.7% [31] of the hip and 0.7% of the lumbar 
spine as averaged to month of duration (n=14 crew members) (Table 2).  For the total hip and femoral 
neck, the percentage BMD loss was greater in the more-metabolically-active trabecular compartment, 
although the BMD loss, on a total mass basis, was greater in the highly dense, cortical bone due to loss 
from the endocortical surface [31]. There was no difference in compartment-specific changes in the 
integral vs. trabecular bone compartments of the spine.  These structural changes at the femoral neck 
imply a reduction in both estimated axial compressive strength and bending strength [31].  The 
reductions in integral volumetric BMDs [31], which measured combined volumetric BMDs of cortical 
and cancellous bone, highlighted the failure of an in-flight exercise program on the ISS to mitigate the 
BMD losses detected by DXA in the crew members of the earlier Mir spacecraft era [28].   
Response on Earth after Spaceflight 
There is evidence that the recovery of space-induced bone loss is delayed in the post-flight 
period. Vico [30] failed to detect any recovery of BMD in the lower limbs of crew members who had 
served 6 months in space. Measurement of BMD by peripheral QCT had been conducted soon after 
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flight and repeated 6 months after landing suggesting that if the skeleton recovered lost BMD it would 
occur on Earth after a period longer than the mission duration [30]. Additionally, Lang et al [32] 
repeated QCT scans at the proximal femur in ISS crew members one year after landing where an 
increase in cross-sectional volume at the femoral neck, compared to the measurements soon after 
landing, was evident but with a persistent depression in volumetric bone mineral density. These data at 
one year post-flight indicate that radial bone growth was stimulated upon return to Earth’s gravitational 
field but that the increased volume remained under mineralized. Furthermore, recovery of volumetric 
BMD in trabecular bone compartment was not evident (Lang, unpublished data). 
The spaceflight-induced geometrical changes at the femoral neck are similar to the adaptive 
response of periosteal osteoblasts to the cortical thinning and trabecular bone loss normally observed 
with age-related bone loss in the elderly [5, 10] suggesting a compensatory physiological response of the 
skeleton to recover compressive and bending strength. QCT analysis of age and sex differences in bone 
geometry [13] similarly documented apposition of bone at the periosteal surface in response to thinning 
of the cortex by age-related increases in bone resorption at the endocortical surface. 
Recently, a novel method of analyzing areal BMD has been reported that characterizes postflight 
skeletal recovery [33]. BMD measurements have been accumulated over a post-flight period lasting as 
long as five years. Data points from a repository of DXA BMD measurements (both cross-sectional and 
longitudinal) of 45 different crew members serving on 56 different missions (4-14 months) were fitted to 
a two-parameter exponential mathematical equation (Figure 5).   The derivation of a “half-life” index 
provided a time point (days after landing) which represented the timing of 50% restoration of BMD with 
Table 3 summarizes the “half-lives” and the losses at the time of landing for the skeletal sites evaluated 
for recovery. In spite of the large variability in the BMD measurements, and the uncertainty in half-life 
values (generally 3-9 months dependent upon skeletal site), the asymptotic increase in BMD over the 
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post-flight period was clearly apparent and provided the basis for substantial recovery at ~ 4 times the 
half-life [33].   
Furthermore, biochemical analyses of bone markers indicated that with return to Earth’s gravity 
there was a reduced NTX excretion in urine, and there was a subsequent increase in serum levels of 
osteoblast-specific proteins (bone specific alkaline phosphatase and osteocalcin)[17] (Figure 6). This 
trend in biomarkers preceded the positive change in BMD, a pattern also observed in the re-ambulatory 
period following bed rest [34]. 
Reductions in Whole Bone Strength 
A Finite Element Analysis [FEA] had been developed from three dimensional images of 
QCT hip scans to determine force to failure for loading of the femoral neck in two orientations: 
the posterior lateral direction (associated with backward falls to the side) and the axial direction 
(associated with stance) [35].  Keyak et al. applied this  FEA to the QCT scans previously 
performed in crew members who served on the space station to determine compartmental bone 
effects [31, 36].  The FEA determined significant reductions in the estimated failure load (i.e., 
hip strength) after the six-month mission relative to the determination made from pre-launch 
scans (Keyak, unpublished data). 
The FEA was applied to QCT scans performed in five crew member subjects 1 year after 
returning providing complete modeling at 3 time points (preflight, postflight and 1 year after return).  
There is a greater trend towards recovery of strength in stance loading (4/5 show minimal recovery in 
fall, 4/5 show strong recovery in stance) (Lang, personal communication).  QCT, however, does not 
have the resolution for trabecular microarchitecture and consequently the FEA [35] may have 
underestimated the impact on hip bone strength.  The same FEA was applied in a cross-sectional 
comparison of hip strength in young vs. elderly women [N=128 (70 – 80 yr) postmenopausal females 
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versus n=30 (35-45 yr) pre-menopausal females] (Keyak, personal communication).   This comparison 
suggested that the reduction in hip strength after 6 months of mechanical unloading by spaceflight was 
comparable to the lifetime reduction in hip strength (for fall loads) in an ageing female. And just as with 
the BMD losses during spaceflight at specific skeletal sites, the greater deficit in hip strength occurred at 
the site within the bone that adapts to weight-bearing while walking and standing on Earth.  
Evidence of decreased bone formation  
Mechanical unloading by spaceflight impairs the mineralization of bone. Histomorphometry of 
tetracycline-labeled iliac crest bone biopsies is the standard method for evaluating mineralization rates 
and mineralizing surfaces in skeletal tissue. However, no bone biopsies have been obtained from a crew 
member before or after flight to assess the impact of spaceflight on either the production or the 
mineralization of matrix.  Histomorphometry data, however, have been obtained from bone biopsies of 
non-human primates that were administered tetracycline prior to being flown in space [37, 28]. 
Compared to biopsies obtained pre-flight and from controls on the ground, there was a significantly 
reduced area of bone (with a tendency for thinner trabeculae) and reduced percentage of mineralizing 
surfaces in biopsies obtained post-flight. Histomorphometric changes were accompanied by a reduction 
in bone mineral content with flight.  
GROUND-BASED ANALOGS OF SPACEFLIGHT UNLOADING OF THE SKELETON  
Spaceflight analogs, both for human test subjects and animals, provide better controlled 
experimental conditions and opportunity for more extensive and invasive analytical methods to evaluate 
the effects of mechanical unloading.  The following list highlights how these analogs are critical for 
corroborating and enhancing the limited spaceflight evidence base which is impacted by the constraints 
associated with mission operations:  a) mechanical unloading by bed rest down-regulates calcium 
regulating hormones [39, 40]; b) mechanical unloading by prolonged bed rest appears to uncouple bone 
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formation and bone resorption as reflected by changes in bone turnover markers [41, 42]; c) mechanical 
unloading appears to uncouple osteoclastic (increases) and osteoblastic (decreases) mediation of bone 
remodeling as determined in bone biopsies [43-45]; d) mechanical unloading, both by bed rest (120 days 
at the time point of biopsy) [46] and by spinal cord injury (2 years following injury) [47], results in a 
loss of connectivity in trabecular microarchitecture; e) mechanical unloading in non-human primates 
immobilized in a spaceflight analog impairs mineralization, accelerates bone resorption, and reduces 
bending strength [48-50].  These analyses of humans and non-human primates in ground-based models 
of mechanical unloading specifically detail the uncoupling of bone remodeling and the activity/number 
of bone cells.  Delineating the impairment in turnover, at the cellular and tissue level, is critical for the 
selection of pharmaceutical countermeasures for the effects of skeletal adaptation in space. 
More recently, the NASA Flight Analogs Project at the Johnson Space Center conducted 
a review of its recently initiated bed rest protocol to evaluate its validity as a standardized test 
bed for studies of mechanical unloading and as a critical research platform for the pre-flight 
evaluation of countermeasures to spaceflight-induced bone loss (and other physiological 
changes). DXA BMD measures in the first 13 test subjects are consistent with BMD changes 
documented in earlier bed rest and in spaceflight studies (Figure 7), with statistically significant 
losses occurring in the hip, pelvis and heel [51]. 
Countermeasures Used to Date 
The primary countermeasure for bone loss employed to date by both the US and Russian space 
programs has been exercise. The approaches used have been reviewed by a number of authors [52-56] 
and evidence suggests that none of the programs have been effective [28, 30, 31] in preventing skeletal 
changes.   
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A treadmill has always been a central component of the Russian countermeasures [53, 57] either 
as an exercise device or as a platform for static exercises [54]. Treadmills on the Russian space stations 
were fixed rigidly to the vehicle and were passive, that is there was no motor and the belt was driven by 
the exercising crew member. The load applied to the body during treadmill exercise in space depends 
critically on the “gravity replacement force” that is applied through a harness and there are no published 
data to indicate the magnitude of forces that were used during Russian countermeasures. A cycle 
ergometer has also been used in the Russian program [52], as has a compression garment called a 
“Pingvin suit” [58].  Despite its widespread use, there is no published evidence that the “Pingvin suit” is 
effective in preventing musculoskeletal changes during spaceflight. 
The first use of exercise by the US space program was the bungee exerciser device flown on 
early Gemini missions, primarily to provide an exercise stimulus that would allow cardiovascular 
responses to be examined [59].  Exercise countermeasures were not conducted during Apollo missions 
and were first introduced by NASA during the Skylab program (1973-1979).  The modalities included a 
Mini-Gym exerciser (a rope and pulley device) and a Teflon plate on which in-place stepping to 
simulate walking and running could be conducted [60].  Calcium balance experiments conducted on 
SkyLab 4 indicated that significant bone loss was occurring despite the countermeasures [61, 62]. 
In the era of short-duration US flights on the Space Shuttle, exercise during the missions was not 
mandatory, partly because of the desire to maximize time available for the performance of experimental 
payload tasks.  However, a stowable passive treadmill known as the “Thornton treadmill” (after its 
developer William Thornton, a physician-astronaut [63]) was flown on many Shuttle missions.  No 
controlled experiments were conducted to determine if exercise on this device was beneficial to bone. 
Long-duration US presence on the International Space Station (ISS) provided the opportunity to 
study the efficacy of exercise countermeasures since each crew member was required to participate in a 
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supervised exercise program. There is a widespread misconception that US astronauts exercise for up to 
2.5 hours per day during their time on-orbit, but quantitative measurements have shown this not to be 
the case [6] since set-up and tear-down activities consume almost 60% of assigned time.   
The exercise modalities available to US crew members during missions to the ISS up to and 
including Increment 16 (2008) were an interim resistance exercise device (iRED [64]); a free floating 
motorized treadmill (TVIS, [65]) that could be used in active or passive mode; and a vibration isolated 
cycle ergometer (CVIS).  Crew members kept careful logs of their exercise bouts on these devices [66], 
and foot forces measurements during exercise in 4 crew members [6] confirmed that low harness forces 
resulted in foot forces that were substantially below those found in similar activities on earth.  This no 
doubt contributed to the lack of efficacy of these countermeasures in preventing bone loss [31]. 
Many questions remain unanswered regarding the optimal prescription of exercise 
countermeasures to prevent bone loss.  The most important of these is whether or not a single “bolus” of 
exercise of any intensity can replace a full day of intermittent loading such as occurs on earth.  An 
additional critical issue is the interaction of concomitant changes in bone and muscle – since the 
integrity of the two systems are intimately connected.  The fact that exercise countermeasures have been 
unsuccessful to date does not mean that they might not be successful in the future once personalized, 
high load exercise of adequate duration is performed.  There is one case study of impact loading that 
appears to have been successful in the calcaneus of a single crew member [67]. 
Based on publicly available information, it appears that no pharmacotherapeutic 
interventions have yet been conducted [68].  This is despite the fact that bisphosphonates have 
been shown to be effective in a bed rest setting [69].  
Knowledge Gaps 
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Because of the many difficulties of conducting research in space, knowledge of changes 
to the skeleton and of appropriate countermeasures has and will be plagued with limitations.  
However, as the space program embarks on longer duration missions, the occupational risks of 
space travel need to be defined if appropriate countermeasures are to be developed.  In terms of 
the risk for early onset osteoporosis, the following is a list of open issues that need to be 
addressed in order to characterize the skeletal adaptation to the mechanical unloading of 
spaceflight: 
• The factors or mechanisms that contribute to the variability in losses of BMD with 
spaceflight have yet to be identified. In particular, the role of genetics remains to be 
elucidated [56]. 
• The impact on whole bone strength is not fully known. Crew member deficits in 
areal BMD as measured by DXA do not reflect changes in “bone quality” or forces 
actually induced on bone during high physical load activity.  There is a need for 
non-invasive assessments of indices known to influence whole bone strength such 
as whole bone geometry, cortical bone thickness or cancellous bone 
microarchitecture, as well as a method to determine force loads on bone.  
• Extensive longitudinal measures over the lifetime of crew members need to be 
conducted to monitor the effects of spaceflight and of recovery. Cross-sectional 
comparisons, such as those conducted with the ageing population, are limited in 
their ability to define patterns of lifetime bone loss for different sites and would not 
provide meaningful information for the management of astronaut long-term health. 
18 
• The impact of spaceflight on balance, coupling, and rate of remodeling has not been 
quantified at the level of the bone remodeling unit; neither have the impacts on cell 
function and number yet been quantified. 
• QCT technology does not have the resolution to assess how loss of volumetric 
BMD in the trabecular compartment affects the microarchitecture. The time course 
and the impact of spaceflight-induced losses on trabecular microarchitecture (i.e., 
trabecular thinning or loss of trabecular connectivity) are unknown. 
• The timing, extent and variability of volumetric BMD recovery in bone 
compartments are still not established. 
• The impact of multiple long-duration flights on bone loss and recovery, and on 
cortical bone thinning and subsequent periosteal expansion, is not known. 
• Sex-based differences in bone loss during spaceflight have not been fully evaluated. 
• The multiple factors that influence the variable rates of BMD recovery between 
individuals after spaceflight have not been assessed. 
• The efficacy of anti-resorptive agents under weightless conditions of spaceflight has 
not been validated. 
• The efficacy of exercise or nutritional countermeasures have not been fully investigated 
or validated. 
• Estimations of whole bone strength for other skeletal sites (arm, wrist, spine) with a 
large number of crew member subjects need to be performed. 
SUMMARY AND CONCLUSION 
The skeletal system of crew members adapts to the gravity unloading by reducing its mineral 
mass through increased bone resorption and uncoupled bone formation. The averaged monthly loss in 
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bone mineral density during a typical 6-month mission in low Earth orbit is 1-2% of pre-flight areal 
BMD (range 6-20% loss per 6 months of spaceflight). The changes in BMD are site-specific and 
geometrical changes in the proximal femur have been associated with decrements in hip strength. There 
is evidence for greater loss in the trabecular compared to cortical compartment. The time course for the 
loss and recovery of bone mass during periods in space and back on Earth, and with various gravity 
levels, has not been determined nor completely characterized. It is necessary to expand skeletal 
measures and to characterize the response of the skeleton to the various levels of loading potentially 
encountered during exploration missions in order to manage any associated skeletal health risks by 
mitigation or treatment.  Countermeasures used to date have not adequately loaded the skeleton to 1G 
levels. 
Substantiating whether spaceflight increases the risk for accelerated osteoporosis ultimately 
centers on determining if spaceflight-induced skeletal changes are irreversible after return to Earth. If 
spaceflight-induced bone loss is not restored and decrements in whole bone strength are not recovered in 
the post-flight period, then crew members will experience the combined effects of space and of ageing 
on the skeleton and be predisposed to an earlier incidence of osteoporosis and fragility fractures. This 
risk will be even greater for female crew members since bone loss with spaceflight will be compounded 
by bone loss with menopause. 
What determines if bone loss and whole bone strength are restored? Pre-flight and post-flight 
measurements of bone should include bone size and geometry, volumetric BMD of bone compartments, 
bone microarchitecture, and mechanical strength testing by computer modeling and virtual loading, as 
developed with these expanded measurements. Additionally, longitudinal measures during the post-
career lifetime of a crew member should be conducted. Moreover, the time course of bone turnover 
during spaceflight will improve the ability to evaluate the risk of longer exposures to skeletal integrity 
20 
and its impact on recovery back on Earth. These additional indices will enhance the probabilistic risk 
assessments for crew members returning from long duration spaceflight missions.  
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Figure legends. 
Figure 1.  History of Early Measures in Space Program.  Ca - calcium; SPA - Single 
Photon Absorptiometry; OH-Pro – Hydroxyproline; NTX –N-telopeptide; DXA – Dual-
energy x-ray absorptiometry; QCT – Quantitative Computed Tomography; DPA – Dual 
Photon Absorptiometry; CT – Computed Tomography; BMD -  Bone Mineral Density. 
Figure 2.  Increases in Activation Frequency in females as a function of menopausal 
status and the number of years following menopause onset.  Activation frequency 
(expressed in year-1) is calculated from histomorphometric indices of bone remodeling 
and serves as a measure of bone turnover.  Adapted figure from [8]. 
Figure 3.  Early determination of changes in calcaneal BMD with spaceflight.  BMD 
(Mean + SE) measured in 3-man crews serving on Skylab missions of varying durations 
and compared to measurements conducted in crew of 14-day missions (Apollo 14, 15 and 
16).  Adapted figure from [15].   
Figure 4 a,b.  Comparison of total hip BMD after spaceflight and in population.  
Changes in DXA-measured BMD male (a) and female (b) crew members serving on 
typical 6-month mission aboard the International Space Station.  BMD change in space is 
compared to 2-year change in population of 239 Danish males (a) and 491 Danish 
females (b).  Adapted figure from [29]. 
Figure 4 c,d.  Comparison of forearm and lumbar spine BMDs after spaceflight and in 
population.  DXA-measured BMD change at the forearm (c) and lumbar spine (d) of 
male crew members serving on typical 6-month mission aboard the International Space 
Station compared to 2-year change in population of 239 Danish males. Adapted figure 
from [29]. 
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Figure 4 e, f.  Comparison of forearm and lumbar spine BMDs after spaceflight and in 
population.  Comparison of DXA-measured BMD change at the forearm (c) and lumbar 
spine (d) of female crew members serving on typical 6-month mission aboard the 
International Space Station compared to 2-year change in population of 491 Danish 
females. Adapted figure from [29]. 
Figure 5.  Recovery of BMD after landing as represented by data from the trochanter.   
Changes between pre- and postflight BMD are plotted as a function of days after landing 
when the scans were performed.  Data points are fitted to a two-parameter equation 
where the intercept of the fitted trochanter data identifies a spaceflight-induced bone loss 
of 7.8% of preflight BMD and a 50% recovery time for the loss to occur after about 8.5 
months. Adapted figure from  [33]. 
Figure 6  a,b.  Bone turnover markers measured in specimens collected pre-flight, during flight 
and after flight suggest that return to Earth’s 1 G environment reverses the increased excretion of 
bone resorption marker (N-telopeptide) and eventually stimulates expression of bone formation 
markers (e.g.,  osteocalcin). Adapted figure from [17]. 
Figure 7.  Changes in BMD after bed rest and spaceflight.  P values based on two-tailed 
Student’s t-test assuming equal variances, bed rest (BR) vs. spaceflight (SF); SF subjects 
are 23 US astronauts from Mir and ISS spaceflights; BR subjects are 13 controls from 
NASA Johnson Space Center Flight Analog bed rest studies [51]. 
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Tables 
Table 1.  Change in BMD (averaged change per month) compared to preflight  
measurement  in crew members serving on missions on the Mir spacecraft [28].  
* signifies p value <0.01. 
Table 2.   Changes in volumetric BMD for combined cortical and cancellous bone 
compartments (“integral”) and for trabecular bone compartment of the lumbar spine, total 
hip and femoral neck.  Significant reductions from baseline (* p value <0.05) in 
volumetric BMD, expressed as loss averaged per month, for all sites with greater 
percentage deficit for trabecular bone of proxmal femur [31]. 
Table 3.  Summary of fitted postflight BMD data per skeletal site.  The percentage of 
preflight BMD loss at the time of landing and the 50% recovery time are listed per 
skeletal site.  Fifty % Recovery time represents the number of days after landing at which 
time there is a restoration of half of the bone mineral that was lost during spaceflight. The 
L0 and recovey times were determined from fitted BMD data to 2-parameter exponential 
equation [33].   
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BMD and Body Composition after 4-14.4 Months of Space Flight 
Variable N %/Month Change SD 
BMD Lumbar Spine 18 -1.06* 0.63 
BMD Femoral Neck 18 -1.15* 0.84 
BMD Trochanter 18 -1.56* 0.99 
BMD Total Body 17 -0.35* 0.25 
BMD Pelvis 17 -1.35* 0.54 
BMD Arm 17 -0.04 0.88 
BMD Leg 16 -0.34* 0.33 
Table 1. 
 
 
QCT Changes in volumetric BMD in 14 ISS Crew members (% per Month + SD)
Lumbar Spine (Integral) -0.9+0.5* 
Lumbar Spine (Trabecular) -1.7+0.6* 
Total Hip (Integral) -1.4+0.8* 
Total Hip (Trabecular) -2.3+0.8* 
Femoral Neck (Integral) -1.2+0.7* 
Femoral neck (Trabecular) -2.7+1.9* 
Table 2 
 
Skeletal Site Loss (L0) at 
landing 
% 
50% Recovery
Time 
(days) 
Femoral Neck 6.8 
(5.7, 7.9) 
211 
(129, 346) 
Trochanter 7.8 
(6.8, 8.8) 
255 
(173, 377) 
Pelvis 7.7 
(6.5, 8.9) 
97 
(56, 168) 
Lumbar Spine 4.9 
(3.8, 6.0) 
151 
(72, 315) 
Calcaneus 2.9 
(2.0, 3.8) 
163 
(67, 395) 
Table 3. 
